Skip to content
Screener

Aura Biosciences, Inc. AURA Shares (Diluted)

Shares (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
1B+20.4%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
88.7M+0.4%
CG Oncology logo
CG OncologyCGON
88.2M+15.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
126.1M+18.4%
LON
LeonaBio, Inc.LONA
19M+387%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$826.46M+87.8%
Enterprise value$758.65M+118%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216808
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Numerator:
Net loss$(33,685)$(27,483)
Denominator:
Weighted-average common stock outstanding—basic and diluted67,447,57650,126,148
Net loss per common share—basic and diluted$(0.50)$(0.55)

Item 1. Financial Statements.

FAQ

What is Aura Biosciences, Inc.'s shares (diluted)?
Aura Biosciences, Inc. (AURA) reported shares (diluted) of 67.4M in Q1 2026.
How has Aura Biosciences, Inc.'s shares (diluted) changed year-over-year?
Aura Biosciences, Inc.'s shares (diluted) increased by 34.6% year-over-year, from 50.1M to 67.4M.
What is the long-term trend for Aura Biosciences, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s shares (diluted) has grown at a 145.6% compound annual growth rate (CAGR), from 6.4M to 234.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Aura Biosciences, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude